SCHEMBL1571372

SCHEMBL1571372

O=[N+]([O-])c1ccc(S(=O)(=O)N2CC2c2ccc(Cl)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.68
KMT2A Q03164 2/20 0.51
RAB9A P51151 1/20 0.51
PSEN1 P49768 2/20 0.47
PSEN2 P49810 2/20 0.47
APH1B Q8WW43 2/20 0.47
NCSTN Q92542 2/20 0.47
APH1A Q96BI3 2/20 0.47
PSENEN Q9NZ42 2/20 0.47
MMP2 P08253 1/20 0.46
PARL Q9H300 1/20 0.46
MMP8 P22894 4/20 0.45
MMP3 P08254 2/20 0.45
ACHE P22303 1/20 0.45
MEN1 O00255 1/20 0.44
TERT O14746 1/20 0.44
MAPT P10636 2/20 0.44
FAAH O00519 1/20 0.44
MGLL Q99685 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1790581 0.86 MAPT (0.58) ALDH1A1KMT2ARAB9AMMP2PARL
SCHEMBL1792783 0.86 MAPT (0.58) ALDH1A1KMT2ARAB9AMMP2PARL
SCHEMBL12614112 0.86 TRPA1 (0.55) ALDH1A1KMT2ARAB9AMMP2PARL
SCHEMBL27981545 0.86 MAPT (0.58) ALDH1A1KMT2ARAB9AMMP2PARL
SCHEMBL1792200 0.86 ALDH1A1 (0.71) ALDH1A1KMT2ARAB9APSEN1PSEN2
SCHEMBL31173291 0.86 ALDH1A1 (0.71) ALDH1A1KMT2ARAB9APSEN1PSEN2
SCHEMBL29620268 0.84 ALDH1A1 (0.58) ALDH1A1KMT2ARAB9APSEN1PSEN2
SCHEMBL28547906 0.84 ALDH1A1 (0.58) ALDH1A1KMT2ARAB9APSEN1PSEN2
SCHEMBL12614703 0.83 ALDH1A1 (0.48) ALDH1A1KMT2ARAB9AMMP2PARL
SCHEMBL1793733 0.83 HSD11B1 (0.61) ALDH1A1KMT2ARAB9AMMP2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112608269-B Method for catalytically synthesizing pyrrolidine by weak interaction of chalcogen 山东大学 2022-05-06 CN disclosed
CN-112608269-A Method for catalytically synthesizing pyrrolidine by weak interaction of chalcogen 山东大学 2021-04-06 CN disclosed
EP-3144303-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2017-03-22 EP disclosed
US-9556139-B2 6-substituted phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA INC. (US) 2017-01-31 US disclosed
EP-2826774-B1 Intermediates for 6-substituted phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA INC (US) 2016-05-25 EP disclosed
US-20150232442-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2015-08-20 US disclosed
US-9096567-B2 6-substituted phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA INC. (US) 2015-08-04 US disclosed
CN-103450138-B Preparation of intermidiates of 6-substituted phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA INC 2015-04-08 CN disclosed
EP-2826774-A1 Intermediates for 6-substituted phenoxychroman carboxylic acid derivatives Array Biopharma, Inc. (US) 2015-01-21 EP disclosed
EP-2307397-B1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2014-08-20 EP disclosed
US-20140221342-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2014-08-07 US disclosed
US-8716498-B2 6-substituted phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA, INC. (US) 2014-05-06 US disclosed
US-20140005418-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2014-01-02 US disclosed
US-8569522-B2 6-substituted phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-10-29 US disclosed
US-20110112288-A1 Metal Porphyrin Catalyzed Olefin Aziridination with Sulfonyl Azides UNIVERSITY OF SOUTH FLORIDA (US) 2011-05-12 US disclosed
US-20110112288-A1 Metal Porphyrin Catalyzed Olefin Aziridination with Sulfonyl Azides UNIVERSITY OF SOUTH FLORIDA (US) 2011-05-12 US disclosed
US-20110112288-A1 Metal Porphyrin Catalyzed Olefin Aziridination with Sulfonyl Azides UNIVERSITY OF SOUTH FLORIDA (US) 2011-05-12 US disclosed
US-20110105463-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2011-05-05 US disclosed
EP-2307397-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2011-04-13 EP disclosed
WO-2009158426-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2009-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221342-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES HRH1, HRH2, HRH4 ALDH1A1 215/4885KMT2A 779/4885RAB9A 128/4885
US-20110105463-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES GPR52, CD22, CD4 ALDH1A1 756/4885KMT2A 466/4885RAB9A 755/4885
US-20150232442-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES GPR52, CD22, CD74 ALDH1A1 783/4885KMT2A 602/4885RAB9A 720/4885
US-20140005418-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES UGT1A6, UGT2B7, UGT1A7 ALDH1A1 67/4885KMT2A 3055/4885RAB9A 894/4885
US-20110112288-A1 Metal Porphyrin Catalyzed Olefin Aziridination with Sulfonyl Azides PPOX, SOD1, AP1S1 ALDH1A1 1473/4885KMT2A 3295/4885RAB9A 1892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.